DAS
TSHA icon

Dynamic Advisor Solutions’s Taysha Gene Therapies TSHA Stock Holding History

Dynamic Advisor Solutions’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-45,000
Closed -$101K – 1003
2024
Q2 		$101K Hold
45,000
– – ﹤0.01% 911
2024
Q1 		$129K Hold
45,000
– – ﹤0.01% 891
2023
Q4 		$80.1K Hold
45,000
– – ﹤0.01% 874
2023
Q3 		$142K Hold
45,000
– – 0.01% 795
2023
Q2 		$29.7K Buy
+45,000
New +$32.6K ﹤0.01% 794

Other funds holding TSHA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Dynamic Advisor Solutions's TSHA Position: Q3 2024 in Review

Dynamic Advisor Solutions sold out of Taysha Gene Therapies (TSHA) in Q3 2024, closing a stake of 45,000 shares — an estimated $101K sold.

Dynamic Advisor Solutions first reported a position in TSHA in Q2 2023 and held it in 5 quarters. The position peaked at $142K in Q3 2023. 119 funds tracked by Wall St. Rank hold TSHA as of Q3 2024.

  • Dynamic Advisor Solutions reported no remaining Taysha Gene Therapies position as of Q3 2024 after selling out during the quarter.
  • Dynamic Advisor Solutions sold 45,000 Taysha Gene Therapies shares in Q3 2024, an estimated $101K.
  • Dynamic Advisor Solutions first reported a position in Taysha Gene Therapies in Q2 2023 and held it in 5 quarters.
  • Dynamic Advisor Solutions's Taysha Gene Therapies position peaked at $142K in Q3 2023.
  • 119 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2024.

Based on Dynamic Advisor Solutions's 13F filing for Q3 2024, filed 7 Oct 2024.